{"id":1538,"date":"2022-09-22T09:39:07","date_gmt":"2022-09-22T07:39:07","guid":{"rendered":"https:\/\/hypertrophiccardiomyopathyacoruna.com\/?page_id=1538"},"modified":"2023-01-24T09:39:46","modified_gmt":"2023-01-24T08:39:46","slug":"programa-preliminar","status":"publish","type":"page","link":"https:\/\/hypertrophiccardiomyopathyacoruna.com\/es\/programa-preliminar\/","title":{"rendered":"Programa preliminar"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; background_image=&#8221;https:\/\/hypertrophiccardiomyopathyacoruna.com\/wp-content\/uploads\/2022\/10\/banner_programa.png&#8221; custom_margin=&#8221;-20px||||false|false&#8221; custom_padding=&#8221;||14px|||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_post_title meta=&#8221;off&#8221; featured_image=&#8221;off&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; title_font=&#8221;|700|||||||&#8221; title_text_align=&#8221;center&#8221; title_text_color=&#8221;#FFFFFF&#8221; title_font_size=&#8221;44px&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_post_title][et_pb_code _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; custom_css_main_element=&#8221;color: #FFFFFF;&#8221; global_colors_info=&#8221;{}&#8221;]<span><span><a href=\"https:\/\/hypertrophiccardiomyopathyacoruna.com\/\">Home<\/a><\/span><\/span>[\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; background_image=&#8221;https:\/\/hypertrophiccardiomyopathyacoruna.com\/wp-content\/uploads\/2022\/10\/fondo_web.png&#8221; custom_padding=&#8221;2px||19px|||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;38px|||||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;||||||||&#8221; header_2_line_height=&#8221;1.4em&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;||||false|false&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<h2>MIOCARDIOPAT\u00cdA HIPERTR\u00d3FICA<\/h2>\n<ul>\n<ul>\n<li>Gen\u00e9tica de la miocardiopat\u00eda hipertr\u00f3fica<\/li>\n<li>Nuevas terapias: terapia g\u00e9nica en miocardiopat\u00eda hipertr\u00f3fica<\/li>\n<li>Inhibidores de la miosina: \u00bfson la \u00abpiedra filosofal\u00bb en el tratamiento de la miocardiopat\u00eda hipertr\u00f3fica?<\/li>\n<li>Controversias en el tratamiento de la Miocardiopat\u00eda Hipertr\u00f3fica Obstructiva<\/li>\n<ul>\n<li>\u00bfTienen un nuevo papel los betabloqueantes?<\/li>\n<li>\u00bfCu\u00e1l es el papel de la miectom\u00eda?<\/li>\n<li>\u00bfLa ablaci\u00f3n septal es segura y efectiva?<\/li>\n<\/ul>\n<li>Controversias en los criterios de estratificaci\u00f3n de riesgo de muerte s\u00fabita en la miocardiopat\u00eda hipertr\u00f3fica<\/li>\n<ul>\n<li>\u00bfDebemos incluir la gen\u00e9tica en el \u00abscore\u00bb de riesgo de muerte s\u00fabita en la miocardiopat\u00eda hipertr\u00f3fica?<\/li>\n<li>Papel del realce tard\u00edo en la cardioresonancia magn\u00e9tica y del aneurisma apical en los criterios de estratificaci\u00f3n de muerte s\u00fabita<\/li>\n<li>Papel de la respuesta de la presi\u00f3n sangu\u00ednea con el esfuerzo<\/li>\n<li>Criterios de estratificaci\u00f3n de riesgo en la poblaci\u00f3n pedi\u00e1trica<\/li>\n<li>Deporte en pacientes con miocardiopat\u00eda hipertr\u00f3fica<\/li>\n<\/ul>\n<\/ul>\n<\/ul>\n<h2>AMILOIDOSIS CARD\u00cdACA TTR<\/h2>\n<ul>\n<ul>\n<ul>\n<li>Nuevos tratamientos en la amiloidosis card\u00edaca por TTR<\/li>\n<li>\u00bfLa gammagraf\u00eda card\u00edaca con DPD o la cardioresonancia magn\u00e9tica son 100% espec\u00edficas en el diagn\u00f3stico de la amiloidosis?<\/li>\n<li>\u00bfCu\u00e1ndo empezar tratamiento en portadores TTR?<\/li>\n<\/ul>\n<\/ul>\n<\/ul>\n<h2>ENFERMEDAD DE FABRY<\/h2>\n<ul>\n<ul>\n<ul>\n<li>\u00bfCu\u00e1ndo empezar el tratamiento en mujeres?<\/li>\n<li>Papel de la cardioresonancia magn\u00e9tica en el diagn\u00f3stico<\/li>\n<li>\u00bfEs la LysoGB3 la soluci\u00f3n en el diagn\u00f3stico y en el seguimiento?<\/li>\n<\/ul>\n<\/ul>\n<\/ul>\n<ul>\n<ul><\/ul>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p><span><span><a href=\"https:\/\/hypertrophiccardiomyopathyacoruna.com\/\">Home<\/a><\/span><\/span>MIOCARDIOPAT\u00cdA HIPERTR\u00d3FICA Gen\u00e9tica de la miocardiopat\u00eda hipertr\u00f3fica Nuevas terapias: terapia g\u00e9nica en miocardiopat\u00eda hipertr\u00f3fica Inhibidores de la miosina: \u00bfson la \u00abpiedra filosofal\u00bb en el tratamiento de la miocardiopat\u00eda hipertr\u00f3fica? Controversias en el tratamiento de la Miocardiopat\u00eda Hipertr\u00f3fica Obstructiva \u00bfTienen un nuevo papel los betabloqueantes? \u00bfCu\u00e1l es el papel de la miectom\u00eda? \u00bfLa ablaci\u00f3n septal es [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-1538","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Programa preliminar - hypertrophic cardiomyopathy 2025<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hypertrophiccardiomyopathyacoruna.com\/es\/programa-preliminar\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Programa preliminar - hypertrophic cardiomyopathy 2025\" \/>\n<meta property=\"og:description\" content=\"MIOCARDIOPAT\u00cdA HIPERTR\u00d3FICA Gen\u00e9tica de la miocardiopat\u00eda hipertr\u00f3fica Nuevas terapias: terapia g\u00e9nica en miocardiopat\u00eda hipertr\u00f3fica Inhibidores de la miosina: \u00bfson la \u00abpiedra filosofal\u00bb en el tratamiento de la miocardiopat\u00eda hipertr\u00f3fica? Controversias en el tratamiento de la Miocardiopat\u00eda Hipertr\u00f3fica Obstructiva \u00bfTienen un nuevo papel los betabloqueantes? \u00bfCu\u00e1l es el papel de la miectom\u00eda? \u00bfLa ablaci\u00f3n septal es [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hypertrophiccardiomyopathyacoruna.com\/es\/programa-preliminar\/\" \/>\n<meta property=\"og:site_name\" content=\"hypertrophic cardiomyopathy 2025\" \/>\n<meta property=\"article:modified_time\" content=\"2023-01-24T08:39:46+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/hypertrophiccardiomyopathyacoruna.com\\\/programa-preliminar\\\/\",\"url\":\"https:\\\/\\\/hypertrophiccardiomyopathyacoruna.com\\\/programa-preliminar\\\/\",\"name\":\"Programa preliminar - hypertrophic cardiomyopathy 2025\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hypertrophiccardiomyopathyacoruna.com\\\/#website\"},\"datePublished\":\"2022-09-22T07:39:07+00:00\",\"dateModified\":\"2023-01-24T08:39:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/hypertrophiccardiomyopathyacoruna.com\\\/programa-preliminar\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/hypertrophiccardiomyopathyacoruna.com\\\/programa-preliminar\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/hypertrophiccardiomyopathyacoruna.com\\\/programa-preliminar\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/hypertrophiccardiomyopathyacoruna.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Programa preliminar\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/hypertrophiccardiomyopathyacoruna.com\\\/#website\",\"url\":\"https:\\\/\\\/hypertrophiccardiomyopathyacoruna.com\\\/\",\"name\":\"hypertrophic cardiomyopathy 2025\",\"description\":\"hypertrophic cardiomyopathy 2025\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/hypertrophiccardiomyopathyacoruna.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Programa preliminar - hypertrophic cardiomyopathy 2025","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hypertrophiccardiomyopathyacoruna.com\/es\/programa-preliminar\/","og_locale":"es_ES","og_type":"article","og_title":"Programa preliminar - hypertrophic cardiomyopathy 2025","og_description":"MIOCARDIOPAT\u00cdA HIPERTR\u00d3FICA Gen\u00e9tica de la miocardiopat\u00eda hipertr\u00f3fica Nuevas terapias: terapia g\u00e9nica en miocardiopat\u00eda hipertr\u00f3fica Inhibidores de la miosina: \u00bfson la \u00abpiedra filosofal\u00bb en el tratamiento de la miocardiopat\u00eda hipertr\u00f3fica? Controversias en el tratamiento de la Miocardiopat\u00eda Hipertr\u00f3fica Obstructiva \u00bfTienen un nuevo papel los betabloqueantes? \u00bfCu\u00e1l es el papel de la miectom\u00eda? \u00bfLa ablaci\u00f3n septal es [&hellip;]","og_url":"https:\/\/hypertrophiccardiomyopathyacoruna.com\/es\/programa-preliminar\/","og_site_name":"hypertrophic cardiomyopathy 2025","article_modified_time":"2023-01-24T08:39:46+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/hypertrophiccardiomyopathyacoruna.com\/programa-preliminar\/","url":"https:\/\/hypertrophiccardiomyopathyacoruna.com\/programa-preliminar\/","name":"Programa preliminar - hypertrophic cardiomyopathy 2025","isPartOf":{"@id":"https:\/\/hypertrophiccardiomyopathyacoruna.com\/#website"},"datePublished":"2022-09-22T07:39:07+00:00","dateModified":"2023-01-24T08:39:46+00:00","breadcrumb":{"@id":"https:\/\/hypertrophiccardiomyopathyacoruna.com\/programa-preliminar\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hypertrophiccardiomyopathyacoruna.com\/programa-preliminar\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/hypertrophiccardiomyopathyacoruna.com\/programa-preliminar\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hypertrophiccardiomyopathyacoruna.com\/"},{"@type":"ListItem","position":2,"name":"Programa preliminar"}]},{"@type":"WebSite","@id":"https:\/\/hypertrophiccardiomyopathyacoruna.com\/#website","url":"https:\/\/hypertrophiccardiomyopathyacoruna.com\/","name":"hypertrophic cardiomyopathy 2025","description":"hypertrophic cardiomyopathy 2025","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hypertrophiccardiomyopathyacoruna.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"}]}},"_links":{"self":[{"href":"https:\/\/hypertrophiccardiomyopathyacoruna.com\/es\/wp-json\/wp\/v2\/pages\/1538","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hypertrophiccardiomyopathyacoruna.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/hypertrophiccardiomyopathyacoruna.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/hypertrophiccardiomyopathyacoruna.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/hypertrophiccardiomyopathyacoruna.com\/es\/wp-json\/wp\/v2\/comments?post=1538"}],"version-history":[{"count":14,"href":"https:\/\/hypertrophiccardiomyopathyacoruna.com\/es\/wp-json\/wp\/v2\/pages\/1538\/revisions"}],"predecessor-version":[{"id":2159,"href":"https:\/\/hypertrophiccardiomyopathyacoruna.com\/es\/wp-json\/wp\/v2\/pages\/1538\/revisions\/2159"}],"wp:attachment":[{"href":"https:\/\/hypertrophiccardiomyopathyacoruna.com\/es\/wp-json\/wp\/v2\/media?parent=1538"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}